Expanded Biomarker Research in Non-Small Cell Lung Cancer Using RNA Next-Generation Sequencing

INVITAE
6/23/21, 3:00 PM
America/New York GMT -4 summer

Description

The discovery of targetable oncogenic biomarkers in non-small cell lung cancer (NSCLC) has revolutionized its treatment. Current guidelines recommend fast and comprehensive biomarker screening for the selection of first-line targeted therapy or immunotherapy with or without chemotherapy. The number of actionable targets and the requirement for extensive molecular screening strategies are expected to increase in the coming years. This webinar will summarize how NSCLC biomarker testing can be expanded by RNA next-generation sequencing.

In this webinar you will learn:

  • The nature of clinical NSCLC biomarker testing in Europe
  • A clinician’s perspective on why the clinical environment should drive the focus of research testing
  • How Invitae’s expanded lung in-house panel* is well positioned to drive successful research testing
Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Expanded Biomarker Research in Non-Small Cell Lung Cancer Using RNA Next-Generation Sequencing

Inglês

 

Speakers

Frédérique Penault-Llorca, Luka Brcic, Verity Johnson